| Date | Form | Description | Docs | XBRL | Pages |
| 07/17/14 | 3 | Initial statement of beneficial ownership of securities |
|
2 | |
| 07/15/14 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
43 | |
| 07/15/14 | 8-K | Current report filing |
|
54 | |
| 07/14/14 | 8-K | Current report filing |
|
5 | |
| 06/26/14 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
3 | |
| 06/26/14 | DEF 14A | Definitive proxy statements |
|
59 | |
| 06/17/14 | UPLOAD | SEC-generated letter |
|
1 | |
| 06/16/14 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
2 | |
| 06/16/14 | PRER14A | Preliminary revised proxy soliciting materials |
|
49 | |
| 06/16/14 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
63 |
Latest News & Events
Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference
Read More...Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology
Read More...Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial
Read More...